Cargando…
Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy
BACKGROUND: The choice of drugs for treatment of advanced gastric cancer (GC) is empirical. The purpose of the current study was to benchmark ex vivo the sensitivity of GC tumor cells from patients to standard cytotoxic and some newly introduced targeted drugs (TDs), as a basis for drug selection in...
Autores principales: | Hultman, Bo, Mahteme, Haile, Sundbom, Magnus, Ljungman, Martin, Larsson, Rolf, Nygren, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304126/ https://www.ncbi.nlm.nih.gov/pubmed/25528067 http://dx.doi.org/10.1186/s13046-014-0110-9 |
Ejemplares similares
-
Prognostic factors in patients with loco-regionally advanced gastric cancer
por: Hultman, Bo, et al.
Publicado: (2017) -
Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer
por: Cashin, Peter H, et al.
Publicado: (2013) -
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015) -
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome
por: Bjersand, Kathrine, et al.
Publicado: (2022) -
Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
por: Cashin, Peter H, et al.
Publicado: (2023)